KACTUS, a leading recombinant protein manufacturer, has published a technical framework for engineering 2+1 and trispecific T-cell engager (TCE) therapeutics.

Drug discovery has long faced a stubborn reality: Most disease-relevant proteins lack the deep, hydrophobic pockets required for inhibition by conventional small-molecule drugs. Beginning in the early ...

Scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. (Nanowerk News) One of the biggest hurdles in developing an HIV ...

Researchers in Brazil have developed a graphene-based scaffold derived from industrial waste that attracted bone cells and promoted fracture repair in laboratory and animal tests. The work, published ...